Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 36 min ago
PreprintCC BYbioRxiv

Structural basis for P-TEFb association with BRD4

  1. 1Massachusetts Institute of Technology

Abstract

Cyclin-dependent kinases (CDK) dynamically regulate RNA Polymerase (Pol) II during each stage of transcription. Phosphorylation of RNA Pol II and associated transcription factors by CDKs enables stage-specific exchange of factors. CDK9 and a cyclin partner (CYCT1, T2 or K) comprise the Positive Transcription Elongation Factor-b (P-TEFb) complex, which is responsible for releasing RNA Pol II from promoter proximal pausing into processive elongation. P-TEFb activity is stimulated by bromodomain-containing Protein 4 (BRD4); however, the structural basis for BRD4 association with P-TEFb has remained unclear. Using cryogenic-electron microscopy, AlphaFold modeling, and biochemical probing, we show that the P-TEFb interacting domain of BRD4 (BRD4-PID) interacts with P-TEFb via the C-lobe of CDK9 and the second cyclin domain of CYCT1. The BRD4 binding surface on CDK9 is also used by super elongation complex component AFF4. Our analysis indicates that BRD4 may stimulate P-TEFb activity by remodeling the kinase C helix relative to previous structures. Finally, P-TEFb activity is restricted when bound to the 7SK RNP complex. We show that in addition to BRD4-PID, the AFF4 N-terminus can release P-TEFb from the 7SK RNP complex. Together, these findings define how P-TEFb activity is regulated by its incorporation into distinct complexes.

Related

  1. Structural basis of endogenous inverse agonism and subtype selectivity at melanocortin receptors
    X. Liu, Q. Sun, S. Zhang +2
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  2. Structural basis of ribosomal RNA repair by RtcB2
    Y. Tian, Q. Zhou, Q. Yu +5
    bioRxivPreprintAll rights reservedFull textGeneral biochemistrybioRxiv
  3. Mechanical regulation of LINC complex function: structural basis, physiological roles, and disease mechanisms in transnuclear mechanotransduction
    Shuoshuo Shao, Zhu Zhu, Huaiquan Liu
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  4. Structural basis for dAMP specificity of the anti-phage deaminase KomA
    Jujun Zhou, Jiahua Wang, John R. Horton +3
    Journal of Biological ChemistryPeer-reviewedLicence not statedMolecular biology & gene regulationCrossref
  5. Structural and biochemical basis for the formation of α-(1→3)-linked mannose residue in O-glycans of Saccharomyces cerevisiae
    Daisuke Hira, Chihiro Kadooka, Takuji Oka
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
BibTeX
@misc{mohamed2026structural,
  title = {{Structural basis for P-TEFb association with BRD4}},
  author = {A. A. Mohamed and S. M. Vos},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.03.749171},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.03.749171v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Structural basis for P-TEFb association with BRD4
AU  - A. A. Mohamed
AU  - S. M. Vos
PY  - 2026
DA  - 2026/09/03
PB  - bioRxiv
DO  - 10.64898/2026.09.03.749171
UR  - https://www.biorxiv.org/content/10.64898/2026.09.03.749171v1
AB  - Cyclin-dependent kinases (CDK) dynamically regulate RNA Polymerase (Pol) II during each stage of transcription. Phosphorylation of RNA Pol II and associated transcription factors by CDKs enables stage-specific exchange of factors. CDK9 and a cyclin partner (CYCT1, T2 or K) comprise the Positive Transcription Elongation Factor-b (P-TEFb) complex, which is responsible for releasing RNA Pol II from promoter proximal pausing into processive elongation. P-TEFb activity is stimulated by bromodomain-containing Protein 4 (BRD4); however, the structural basis for BRD4 association with P-TEFb has remained unclear. Using cryogenic-electron microscopy, AlphaFold modeling, and biochemical probing, we show that the P-TEFb interacting domain of BRD4 (BRD4-PID) interacts with P-TEFb via the C-lobe of CDK9 and the second cyclin domain of CYCT1. The BRD4 binding surface on CDK9 is also used by super elongation complex component AFF4. Our analysis indicates that BRD4 may stimulate P-TEFb activity by remodeling the kinase C helix relative to previous structures. Finally, P-TEFb activity is restricted when bound to the 7SK RNP complex. We show that in addition to BRD4-PID, the AFF4 N-terminus can release P-TEFb from the 7SK RNP complex. Together, these findings define how P-TEFb activity is regulated by its incorporation into distinct complexes.
ER  -